ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -15.4% ·
Aktienfluss -0.5% ·
neue Nettopositionen -18.2%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passiv) | 5.38M | +2.6% | $107.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 5.38M | +2.6% | $107.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 5.26M | -22.9% | $105.23M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 5.26M | -22.9% | $105.23M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 3.67M | +42.0% | $73.31M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 3.59M | -10.8% | $71.79M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.10M | +1.1% | $41.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.10M | +1.1% | $41.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.75M | +163.0% | $34.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.12M | +18.7% | $22.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 164.56K | +110.6% | $3.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 111.01K | +7.3% | $2.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Citadel Advisors | $339,324 | war 0.0% |
| Marshall Wace | $299,624 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 355 Inhaber, 211.31M Anteile, $1.84B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.